A multicenter study led by investigators at Johns Hopkins University just reported on a full genomic analysis of tumor samples from a small number of people who died of pancreatic cancer. The new data suggests that epigenetic changes control how DNA operates to confer survival advantages on subsets of pancreatic cancer cells. Those advantages, the researchers say, let such cancer cells thrive in organs like the liver and lungs, which receive a sugar-rich blood supply.
Tuesday, January 31 at 2:00 PM ET
You’ve got an amazing idea for a new medical product, it’ll save lives, speed recovery, be less expensive, more accurate and durable than the product already available on the market – or it may fill a gap where there is no product available. You have an amazing team, strong IP, an understanding of the regulatory and reimbursement coverage data requirements – all you need to get to market is MORE MONEY! In this Small Biz Hangout one of NHLBI’s funded companies will demonstrate how to deliver a strong pitch to investors and our Investor-in-Residence will comment on the most effective and impactful aspects of the delivery.
In a dream Brian Hanley told me about, he’s riding a bus when he meets a man in dark leather clothing. Next thing he knows, he is splayed across a tilted metal bed, being electrocuted.
A half-dozen student-run startups at Johns Hopkins are getting some funding and help with developing their ideas.
Through the O’Connor Fund, the undergraduate student teams get a $5,000 grant plus access to mentors and other resources. There’s also an opportunity to receive another $5,000 if the teams reach specific business milestones. The program is run by Johns Hopkins Tech Ventures.
The Accelerator Director serves as a principal member of the IPHA evaluation, selection and mentoring team responsible for the identification and development of new personalized health companies with the potential to produce disruptive technology solutions and achieve a high rate of growth.
The Accelerator Director is responsible for sourcing and conducting due diligence on IPHA applicants, evaluating and supporting new company formation strategies, mentoring entrepreneurs in personalized health product development, facilitating IPHA member network relationship development, maintaining board-level relationships and mentoring entrepreneurs in securing equity based capital for growth.
Additionally, the Director will support the growth and management of the IPHA mentor network whose participants provide guidance to portfolio companies. The Director will also work with members of the Inova Strategic Investment team to support the diligence process prior to subsequent investment transactions.
Geisinger Health System CEO Dr. David Feinberg used the StartUp Health Festival to launch its population health initiative, Springboard Health during the J.P. Morgan Healthcare Conference in San Francisco this week.
Massachusetts stole a second straight victory in Bloomberg’s ranking of the most innovative U.S. states, a testament to how much the economy’s wheels are greased by investment in higher education and research.
Venture capitalists invested $300 million in Maryland companies in 2016, a 70 percent drop from $1 billion the year before.
In the Obama administration’s final days, the National Cancer Institute is establishing an ambitious new program designed to allow scientists to more quickly access new drugs and compounds for novel research.
One of the last achievements of Vice President Joe Biden’s cancer moonshot initiative before he leaves office, the program was unveiled Wednesday and will begin as an agreement between the institute and six drug companies.
The search is on for the Best University Startups of 2017. We are calling all universities and their startups to apply and be considered to present live at the next University Startups Conference and Demo Day on April 18-20, 2017 in Washington, D.C.
The National Council of Entrepreneurial Tech Transfer (NCET2) will hold its second University Startups Demo Day (USDD) at the Washington Convention Center in Washington, DC on April 18-20, 2017.
